Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-20-000110
Filing Date
2020-02-13
Accepted
2020-02-13 16:30:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 catabasis13ga2019.htm SC 13G/A 56308
  Complete submission text file 0000935836-20-000110.txt   57864
Mailing Address 919 NW BOND STREET SUITE 204 BEND OR 97703
Business Address 919 NW BOND STREET SUITE 204 BEND OR 97703 541.647.5664
Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

EIN.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Subject) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88910 | Film No.: 20611088
SIC: 2834 Pharmaceutical Preparations